Blood component therapy guided by celite-activated thromboelastography for perioperative coagulopathy

Journal of Anesthesia

Volumn 16, Issue 1, 2002, Pages 79-83

  Kawasaki, Jun ^a   Tanaka, Kenichi A ^b   Sato, Nobukazu ^b   Saitoh, Toshie ^a   Shimizu, Masahiro ^a   Kawazoe, Taro ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Coagulopathy; Fibrinolysis; Intraoperative monitoring; Platelet defects; Thromboelastogram

Indexed keywords

APROTININ; FRESH FROZEN PLASMA; HEPARIN; HEPARIN LYASE; INFUSORIAL EARTH; MILRINONE; NORADRENALIN; PROTAMINE; TRANEXAMIC ACID; WARFARIN;

ABDOMINAL BLEEDING; ADULT; ANESTHESIA INDUCTION; ARTICLE; BLOOD CLOTTING DISORDER; BLOOD COMPONENT THERAPY; CASE REPORT; CESAREAN SECTION; CORONARY ARTERY BYPASS GRAFT; CRYOPRECIPITATE; ERYTHROCYTE TRANSFUSION; FEMALE; GENERAL ANESTHESIA; HIGH RISK PATIENT; HUMAN; LAPAROTOMY; MALE; PATIENT CARE; PATIENT MONITORING; PERIOPERATIVE PERIOD; PREGNANCY; STILLBIRTH; SURGICAL PATIENT; THROMBOCYTE TRANSFUSION; THROMBOELASTOGRAPHY; TRAFFIC ACCIDENT;

EID: 0036205676     PISSN: 09138668     EISSN: None     Source Type: Journal    
DOI: 10.1007/s540-002-8099-5     Document Type: Article

References (11)

1. Blutgerinnungsstudien mit der Thrombelastographie, einem neuen Untersuchungsverfahren
2. Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation
3. Assessment of changes in coagulation in parturients with preeclampsia using thromboelastography
4. Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery
5. Thromboelastography as an indicator of post-cardiopulmonary bypass coagulopathies
6. Thrombelastography as a bedside monitor of coagulation and fibrinolysis during surgery. A report of three cases (in Japanese with English abstract)
7. Thromboelastographic changes in healthy parturients and postpartum women
8. The usefulness of celite-activated thromboelastography for evaluation of fibrinolysis
9. Effect of analytic uncertainty of conventional and point-of-care assays of activated partial thromboplastin time on clinical decisions in heparin therapy
10. Monitoring platelet glycoprotein IIb/IIIa-fibrin interaction with tissue factor-activated thromboelastography
11. Reduced hemostatic factor transfusion using heparinase-modified thromboelastography (TEG) during cardiopulmonary bypass (CPB)